A molecular epidemiological approach to the study of expression of a metastasis marker in primary melanomas and its correlation with individual patient's risk of recurrence or metastasis

Melanoma Research

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Doré, Jean François ^a   Maisonneuve, Patrick ^b   Cattaruzza, Maria Sofia ^b   Autier, Philippe ^b   Cochran, Alistair J ^c   Boyle, Peter ^b  

^a CENTRE LÉON BÉRARD   (France)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Case control study; Individual risk; Malignant melanoma; Prognostic factors; Recurrence; Stage I melanoma; Subgroups analysis; Survival

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; SKIN METASTASIS;

EID: 0030777913     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg 1992; 16C:21-1-221.
2. Balch CM, Houghton AN, Peters LJ. Cutaneous Melanoma. In Cancer. Principles and Practice of Oncology. 4th Edn, Vol 2. Edited by De Vita VT, Hellman S, Rosenberg SA. Philadelphia: JB Lippincott, 1993:1612-1661.
3. Doré IF, Carrel S. Biology of Melanoma. Differentiation and progression. In Malignant Melanoma: Medical and Surgical Management. Edited by Lejeune FJ, Chaudhuri PK, Das Gupta TK. New-York: McGraw-Hill. 1994:9-26.
4. Hakomori SI. Aberrant glycosylation in cancer cell membranes focused on glycolipids: overview and perspectives. Cancer Res 1985; 45:2405-2414.
5. Passaniti A, Hart GW. Cell surface sialylation and tumor metastasis: metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharides structures. J Biol Chem 1988; 263:7591-7603.
6. Bailly M, Bertrand S, Doré J F. Human tumor spontaneous metastasis in immunosuppressed newborn rats. I. Characterization of the bioassay. Int J Cancer 1991; 49:457-466.
7. Bailly M, Doré JF. Human tumor spontaneous metastasis in immuno-suppressed newborn rats. II, Multiple selections of human melanoma metastatic clones and variants. Int J Cancer 1991; 49:750-757.
8. Bailly M, Doré JF. Clonal drift and rule of chromosome dosage in human melanoma metastatic cell lines: a statistical analysis. Anticancer Res 1992; 12:1163-1172.
9. Bailly M, Bertrand S, Doré JF. Increased spontaneous mutation rates and prevalence of karyotype abnormalities in highly metastatic human melanoma cell lines. Melanoma Res 1993; 3:51-61.
10. Berthier-Vergnes O, Berrux V, Réano A, Dore JF. Expression of cell surface sialic acid and galactose by normal adult human melanocytes in culture. Pigment Cell Res 1990; 3:55-60.
11. Zebda N, Pedron S, Rebaa A, Portoukalian J, Berthier-Vergnes O. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells. Relevance of CMP-NeuAc-Lac-Cer α2-3 sialyl transferase (GM3 synthase). FEBS Lett 1995, 362:161-164.
12. Zebda N, Bailly M, Brown S, Doré JF, Berthier O. Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 1994; 54:161-173.
13. Berthier-Vergnes O, Zebda N, Bailly M, et al. Expression of peanut agglutinin-bindingglycoconjugates in primary melanomas with high risk of metastases. Lancet 1993; 341:1292.
14. Lejeune FJ, Macher E, Kleeberg UR, et al. An assessment of DTIC versus levamisole or placebo in the treatment of high risk stage I patients after surgical removal of a primary melanoma of the skin. A phase II adjuvant study. EORTC Protocol 18761. Eur J Cancer 1988; 24 (suppl 1):S81-S90.
15. Avril MF, Clerc F. Natural history of skin cancer [Histoire naturelle des cancers de la peau). In Sun and Melanoma. Analysis of Skin Cancer Risks. Prevention Methods [Analyse des Risques de Cancers Cutanés. Moyens de Prévention]. Edited by Doré JF, Muir CS, Clerc F. Paris: INSERM La Documentation Francaise, 1990: 17-46.
16. Suciu S. Statistical analysis and data management. In Malignant Melanoma. Medical and Surgical Management Edited by Lejeune FJ, Chauduri PK, Das Gupta TK. New York: McGraw-Hill, 1994:361-371.
17. Breslow NE. Day NE. Statistical Methods in Cancer Research. The Analysis of Case-Control Studies. IARC Scientific Publication No. 32. Vol 1. Lyon: IARC, 1980.
18. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993, 55:765-770.
19. Burton RC, Armstrong BK. Recent incidence trends imply a non-metastasizing form of invasive melanoma. Melanoma Res 1994. 4:107-113.